glp-1 supply chain news Retailers across the country are noticing a spike in returns of clothing as more Americans embrace drugs for weight loss. The rate of retail exchanges where shoppers traded clothing for a GLP-1 Receptor Agonist Market Size,

The available evidence indicates quite convincingly that SSRI use may play a causal role in upper gastrointestinal bleeding and that these drugs may act synergistically with other bleeding risk-increasing medications such as NSAIDs or low-dose aspirinPatients should be informed about the likelihood of possible upper gastrointestinal bleeding and high-risk patients should be followed closely. Psychiatric Drugs and ALS A research team at the Karolinska Institute in Sweden announced a worrisome drug complication ( JAMA Network Open , June 4, 2025)

Anticipated Utilization Increases Expanded Eligibility: Coverage for obesity treatment could lead to a 40%60% increase in GLP-1 utilization over the first two years, with an estimated 1.52.5 million additional beneficiaries initiating therapy annually across Medicare and Medicaid

Matt Eaves Thats really interesting

A Standardized dataset of a spontaneous adverse event reporting system

Based on animal studies, Eli Lilly warns that Mounjaro may cause fetal harm